Abstract
Head and neck cancer, together with cancers of the esophagus and lung, will cause one third of all 1990 cancer deaths in the United States, or 160,000 deaths (1). The magnitude of this problem directly relates to the magnitude of tobacco use, since tobacco is the single causative agent linking these three aerodigestive tract cancers. Despite intensified attention to smoking cessation programs, tobacco continues to be a major public health problem throughout the world. Worldwide tobacco use statistics include 1 billion smokers and 600 million chewers; U.S. figures are 50 million smokers and 12 billion chewers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. CA 40:9–26, 1990.
Hong WK, Bromer R. Chemotherapy in head and neck cancer. N Engl J Med 308:75–79, 1983.
Hong WK, Bromer RH, Amato DA, Shapshay S, Vincent M, Vaughan C, Willett B, Katz A, Welch J, Fofonoff S, Strong MS. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 56:1242–1245,1985.
Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-sage disease (editorial). Ina J Radiat Oncol Biol Phys 17:691–694, 1989.
Slaughter DP, Southwick HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium: Clinical implications of multicentric origin. Cancer 6:963–968, 1953.
Devesa SS, Silverman DT, Young JL, Pollack ES, Brown CC, Horn JW, Percy CL, Myers MH, McKay FW, Fraumeni JF Jr. Cancer incidence and mortality trends among whites in the United States. J Natl Cancer Inst 79:701–741,1987.
Decker J, Goldstein JC. Risk factors in head and neck cancer. N Engl J Med 306:1151–1155,1982.
Brandsma J, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 115:621–625,1989.
Spitz MR, Fueger JJ, Bcddingfield NA, Annegcrs JF, Hsu TC, Newell GR, Schantz SP. Chromosome sensitivity to bleomycin-induced mutagenesis: An independent risk factor for upper aer digestive tract cancers. Cancer Res 49:4626–4628, 1989.
Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature 290:201–208, 1981.
Bertram JS, Kolonel LN, Meyskens FL Jr. Rationale and strategies (Or chemoprevention of cancer in humans. Cancer Res 47:3012–3031, 1987.
Ziegler RG. A review of epidemiologic evidence thatcarotenoids reduce the risk of cancer. J Nutr 119:116–122, 1989.
Winn DM, Ziegler RG, Pickle LW, Gridley G, Blot WJ, Hoover RN. Diet in the etiology of oral and pharyngeal cancer among women from the southern United States. Cancer Res 44:1216–1222, 1984.
Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents. Cancer Treatment Reports 71(4) Part I:391–405,71(5) Part II:493–515, 1987.
Lippman SM, Lee JS, Lotan R, Hiuelman W, Wargovich MJ, Hong WK. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 82:550–560, 1990.
Lippman SM, Hong WK. Differentiation therapy for head and neck caner. In Snow G, Clark JR (eds). Multimodality Therapy for Head and Neck Cancer. New York: Georg Thieme Verlag, in press.
Lippman SM, Lee JS, Lotan R, Hong WK. Chemoprevcntion of Upper Aerodigestive Cancer Task Force Workshop. Head Neck 12:5–20, 1990.
Evans RM. The steroid and thyroid hormone receptor superfamily. Science 240:889–895, 1988.
Tornita Y, Himeno K, Nomoto K, Endo H, Hirohata T. Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene. J Natl Cancer Inst 78:679–681,1987.
Murakoshi M, Takayasu J, Kimura O, Kohmura E, Nishino H, Iwashima A, Okuzumi J, Sakai T, Sugimoto T, Imanishi J. Inhibitory effects of alpha-carotene on proliferation of the human neuroblastoma cell line GOTO. J Natl Cancer Inst 81:1649–1652,1989.
Napoli JL, Race KR. Biogenesis of retinoic acid from β-carotene: Differences between the metabolism of β-carotene and retinol. J Biol Chem 263:17372–17377, 1988.
Stich HF, Rosin MP, Homby AP, Mathew B, Sankaranarayanan R, Nair MK. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 42:195–199, 1988.
Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 40:93–101, 1988.
Garewal H, Allen V, Killen D, Elletson H, Reeves D, King D, Meyskens F. Beta-carotene (BC) is an effective, non-toxic agent for the treatment ofpremalignant lesions of the oral cavity (abstract). Proceedings of the American Society of Clinical Oncology Annual Meeting 8:167, 1989.
Toma S, Albanese E, De Lorenzi M, Nicolo G, Mangiante P, Galli A, Cancedda R. Beta-carotene in the treatment of oral leukoplakia (abstract). Proceedings of the Annual Meeting of the American Society of Clinical Oncology 9:179, 1990.
Lippman SM, Garewal HS, Meyskens FL Jr. Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Prey Med 18:740–748, 1989.
Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper P, Strong S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501–1505, 1986.
Lippman SM, Toth BB, Bassakis JG, Lee JS, Weber RS, McCarthy KS, Martin JW, Hay SG, Wargovich MJ, Lotan R, Hong WK. Low-dose 13-cis-retinoic acid (13cRA) maintains remission in oral premalignancy: More effective than β-carotene in randomized trial (abstract). Proceedings of the Annual Meeting of the American Society of Clinical Oncology 9:225, 1990.
Hong WK, Lippman SM, Ori LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LT, Dimery IW, Brown BW, Goepfert H. Prevention of second primary tumors in squamous cell carcinoma of the head and neck with 13-cis-retinoic acid. N Engl J Med 323:795–800, 1990.
Lippman SM, Kessler JF, Al-Sarraf M, Alberts DS, Uri LM, Mattox D, Von Hoff DD, Loescher L, Meyskens FL. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: A phase II randomized trial. Invest New Drugs 6:51–56, 1988.
X MJ, Pneg UM, Liu Y, Alberts DS, Plezla PM, Sayers SM. Effect of chronic oral administration of β-carotene on plasma α-tocopherol concentrations in nonnal subjects (abstract). Proceedings of the American Association for Cancer Research 31:126, 1990.
Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 318:1633–1637, 1988.
Lippman SM, Meyskens FL Jr. Treatment of advanced squamouscell carcinomaof theskin with isotretinoin. Ann Intern Med 107:499–502, 1987.
Besa EC, Abrahm JL, Nowell PC. Comparison of efficacy and toxicity of 13-cis-retinoic acid (RA) with or without alpha tocopherol in myelodysplasia (abstract). Proceedings of the American Society of Hematology 70:222a, 1987.
Modiano MR, Dalton WS, Lippman S M, Joffe L, Booth AR, Meyskens FL Jr. Ocular toxic effects of fenretinide. J Nall Cancer Inst. 82:1063,1990.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lippman, S.M., Hong, W.K. (1992). Chemoprevention of Aerodigestive Epithelial Cancers. In: Newell, G.R., Hong, W.K. (eds) The Biology and Prevention of Aerodigestive Tract Cancers. Advances in Experimental Medicine and Biology, vol 320. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3468-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3468-6_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6536-5
Online ISBN: 978-1-4615-3468-6
eBook Packages: Springer Book Archive